61 – 70 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
(
- Contribution to journal › Letter
-
Mark
Risk of developing diabetes is inversely related to lung function: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Glycaemic control, disease duration and beta-cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project.
(
- Contribution to journal › Article
- 2001
-
Mark
Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR)
(
- Contribution to journal › Article
-
Mark
Metabolic effects of metformin in patients with impaired glucose tolerance
(
- Contribution to journal › Article
- 2000
-
Mark
Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg Hypertension and Diabetes Project
(
- Contribution to journal › Article
- 1999
-
Mark
Increased aortic stiffness in women with type 1 diabetes mellitus is associated with diabetes duration and autonomic nerve function
(
- Contribution to journal › Article
- 1997
-
Mark
Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in Type 1 diabetic patients
(
- Contribution to journal › Article
-
Mark
Burden of illness, metabolic control, and complications in relation to depressive symptoms in IDDM patients
(
- Contribution to journal › Article